News Image

Taylor Morrison Home Corp (NYSE:TMHC): A Value Investment Case in Residential Construction

By Mill Chart

Last update: Oct 8, 2025

Value investing represents a time-tested approach to identifying companies trading below their intrinsic worth. This strategy, pioneered by Benjamin Graham and famously practiced by Warren Buffett, focuses on finding securities that the market has undervalued despite solid underlying fundamentals. The methodology involves detailed analysis of financial metrics to find differences between a company's market price and its true business value. By applying systematic screening criteria, specifically seeking stocks with strong valuation scores while maintaining acceptable profitability, financial health, and growth characteristics, investors can identify potential opportunities that meet the strict standards of value investing principles.

TMHC Stock Chart

TAYLOR MORRISON HOME CORP (NYSE:TMHC) presents a noteworthy case for value investors seeking opportunities in the residential construction sector. The company's fundamental profile demonstrates several characteristics that align with value investing criteria, particularly through its attractive valuation metrics combined with sustainable business operations.

Valuation Metrics

The company's valuation profile stands out as particularly interesting for value-oriented investors. Taylor Morrison trades at significant discounts across multiple valuation metrics compared to both industry peers and broader market indices:

  • Price-to-Earnings ratio of 7.32, substantially below the industry average of 22.09 and the S&P 500's 27.76
  • Price-to-Forward Earnings of 8.11, cheaper than 87% of industry competitors
  • Enterprise Value to EBITDA ratio positioning the company as more affordable than 79% of industry peers
  • Price-to-Free Cash Flow ratio ranking more favorably than 83% of comparable companies

These valuation metrics are crucial for value investors because they indicate potential margin of safety—a core principle in value investing that provides protection against estimation errors in intrinsic value calculations. The significant discounts across multiple valuation measures suggest the market may be undervaluing the company's true worth.

Financial Health Assessment

Taylor Morrison demonstrates acceptable financial health with a ChartMill Health Rating of 6 out of 10. The company maintains several positive financial characteristics:

  • Strong current ratio of 5.97, outperforming 79% of industry competitors
  • Conservative debt-to-equity ratio of 0.35, indicating limited dependence on debt financing
  • Altman-Z score of 3.87, suggesting no immediate bankruptcy concerns
  • Consistent reduction in shares outstanding over multiple years

However, investors should note the company's quick ratio of 0.32, which falls below industry standards and may indicate potential short-term liquidity constraints. For value investors, financial health is paramount because it reduces the risk of permanent capital loss while waiting for the market to recognize the company's intrinsic value.

Profitability Profile

The company performs well in profitability with a ChartMill Profitability Rating of 7 out of 10. Taylor Morrison demonstrates strong operational efficiency through multiple metrics:

  • Profit margin of 10.72%, surpassing 86% of industry peers
  • Operating margin of 15.01%, better than 87% of competitors
  • Return on invested capital of 11.58%, exceeding 75% of industry counterparts
  • Consistent positive earnings and operating cash flow over five consecutive years

These profitability metrics are essential for value investors because they indicate sustainable business operations and the company's ability to generate returns above its cost of capital—key factors in determining intrinsic value and long-term investment potential.

Growth Considerations

Taylor Morrison shows a mixed growth profile with a ChartMill Growth Rating of 5 out of 10. The company has demonstrated strong historical performance:

  • Earnings per share growth of 26% over the past year
  • Average EPS growth of 23% annually over recent years
  • Revenue growth of 14% in the past year with 11% average annual growth

However, future growth projections appear more modest, with expected EPS growth of 4% and revenue growth of less than 1% annually. This divergence between historical performance and future expectations may contribute to the company's discounted valuation. For value investors, understanding growth trajectories helps determine whether current undervaluation represents a temporary market disconnect or fundamental business challenges.

Investment Considerations

The combination of deeply discounted valuation metrics with solid profitability and acceptable financial health makes Taylor Morrison an interesting candidate for value investors. The company's strong margins and returns on capital suggest operational efficiency, while its valuation multiples indicate potential undervaluation relative to both industry peers and the broader market.

Value investors typically seek companies trading at significant discounts to their intrinsic value while maintaining fundamental strength—precisely the profile Taylor Morrison presents. The company's reduced share count demonstrates management's capital allocation discipline, while its consistent profitability suggests business model durability.

View the complete fundamental analysis report for Taylor Morrison to examine all metrics in detail.

For investors seeking similar opportunities, our Decent Value Stocks screen regularly identifies companies with attractive valuations and solid fundamentals across various sectors.

Disclaimer: This analysis is for informational purposes only and does not constitute investment advice, recommendation, or endorsement of any security. Investors should conduct their own research and consult with financial advisors before making investment decisions. Past performance does not guarantee future results, and all investments carry risk including potential loss of principal.

TAYLOR MORRISON HOME CORP

NYSE:TMHC (10/10/2025, 9:00:12 PM)

After market: 61.3 0 (0%)

61.3

-0.71 (-1.14%)



Find more stocks in the Stock Screener

TMHC Latest News and Analysis

Follow ChartMill for more